Natco Pharma Limited — Others, 08-07-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Natco Pharma has announced a board meeting to consider the financial results for the quarter and half-year. The company submitted the compliance certificate confirming all securities received for dematerialization were duly cancelled and updated in the depositories’ records within the stipulated timeframe. This ensures the accuracy of shareholder registers and facilitates uninterrupted trading for investors. The timely update supports transparent shareholding and regulatory compliance, maintaining investor confidence.